Patient Issues

Vanderbilt’s Stacie Dusetzina and colleagues explain how the ‘copay adjustment’ programs work in this week’s JAMA Internal Medicine and...

The New York Times The Times reported last month that drug shortages in the United States are approaching record levels, with thousands...

This week American Pharmacy Cooperative, Inc. (APCI) took a bold step  in the ongoing campaign for PBM reform: they openly called on Vanguard Inc., the largest investor of in the parent companies of the “Big 3” pharmacy benefit managers (PBMs), to use its influence to curtail their PBMs’ abuse of patients and pharmacies.  “As one of the largest investors in United Healthcare, CVS, and Cigna, Vanguard is in a unique position to help effectuate real and meaningful change on beh

Washington Post Opinion Author: Elisabeth Rosenthal Millions of Americans in the past few years have run into this experience: filing a...

Over the last five years, both PBMs and drug manufacturers have implemented restrictions that put more of the costs for specialty...

Ohio Capital Journal The prescriptions with the most eye-popping price tags — like cancer meds that can cost more than $20,000 a month —...

Learn how to request your health insurance claim file, which can include details about what your insurer is saying about you and your...

Pharmaceutical companies have cut financial assistance to thwart health-plan tactics The Wall Street Journal It is getting tougher for...

HCP Live Click Here to Watch the Video of Juliana Reed's Talk Juliana Reed, MS, executive director of the Biosimilars Forum, discussed...

Minnesota Reformer Kemper Drug in Elk River recently closed its doors for the last time after having served the community for over 70...

STAT+ News An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered...

For Too Long, Insulin Manufacturers and Pharmacy Benefit Managers Have Derived Unjust Economic Benefit from Diabetes Patients and State Taxpayers. Attorney General Landry Seeks to Reverse the Damage Louisiana Independent Pharmacies Association BATON ROUGE, LA (March 15, 2023) – Louisiana Independent Pharmacies Association (LIPA) issued the following statement in response to Attorney General Jeff Landry’s lawsuit naming Sanofi-Aventis U.S., LLC and Novo Nordisk, Inc, two the

Louisiana KTAL News Louisiana Attorney General Jeff Landry announces a new lawsuit aimed at protecting diabetic residents from high costs...

Pharmacy benefit managers say they exclude high-cost drugs and have alternatives on their formularies. Critics say exclusions narrow...

CMS rule leaves high out-of-pocket costs, lawsuit argues Aid programs ‘mask’ problem of prices, analysts say Bloomberg Law High drug...

Forbes President Biden’s State of the Union Address hammered home the point that drug prices must come down. He reminded viewers that he...

KHN After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate...

New laws target a health insurance practice called “step therapy,” which is used to control costs, but can also delay needed treatment...

Oklahoma KFOR News The Oklahoma Pharmacy Board unanimously approved new rules Wednesday that would regulate how Oklahomans receive...

As a health and science reporter, I’ve studied the maze of U.S. health care. But when my son got sick, I still got lost. The Washington...